Skimping on Research Funds

Research spending dropped $4 billion dollars in 2011, and could continue to drop, according to a new report.

Written byBeth Marie Mole
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Wikimedia, Argonne National LaboratoryThe amount of total money spent on biomedical and health research fell by $4 billion, or 3 percent, between 2010 and 2011, mostly due to large budget cuts from federal sources, with a total budget of around $136 billion, according to the 2011 U.S. Investment in Health Research report, released by Research!America yesterday (October 25). Pending budget cuts as a result of sequestration threaten to knockdown research spending by up to another 10 percent—or $13.6 billion dollars—in 2013.

“Insufficient funding, coupled with deep budget cuts under sequestration, could be devastating for research,” Research!America’s chair John E. Porter said in a press release. “Our global competitiveness hinges on a robust investment that will support bright scientific minds, create high-quality jobs and provide a catalyst for private sector innovation.”

The report found that the federal government contributed $39.5 billion in research funding last year, down 14 percent from the previous year’s $45.9 billion. Meanwhile, private industry funding increased by 1.4 percent from 2010, up to $77.6 billion in 2011, and university funding increased by 6 percent, up to $11.9 billion.

In contrast, the report points out that China has pledged to invest $308.5 billion in biotechnology research over the next 5 years. “As R&D spending ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies